CTOs on the Move

Valeant Pharmaceuticals

www.valeant.com

 
Valeant Pharmaceuticals International, Inc. is a diverse and decentralized pharmaceutical company that is committed to focusing on our key stakeholders while delivering consistently high performance. Our values provide the overall direction for our company, and provide us with the tools necessary to rise to any challenge by leveraging our collective hard work and effort along with our unwavering competitive spirit. These values help us set goals based on our organization’s potential and what we hope it will become.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.valeant.com
  • 2150 St. Elzéar Blvd. West
    Laval, QC CAN H7L 4A8
  • Phone: 514.744.6792

Executives

Name Title Contact Details
Michael McDaid
Vice President of Information Technology Profile

Similar Companies

LTS LOHMANN Therapy-Systems

LTS offers a wealth of experience in adhesive formulation and coating technology to manufacture and supply specialty laminates intermediates for many applications. Our products are tailored to our customers' needs and are targeted for use in

PolyPeptide Group

PolyPeptide Labs is a world leader in the manufacture of polypeptide, custom peptide Synthesis, peptide synthesis and generic peptide : generic GMP peptide and non-GMP peptide. PolyPeptide provides global support for a quality solution.

Argos Therapeutics

Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its Arcelis™ technology platform. Using biological components from each patient, Arcelis-based immunotherapies employ the patient`s dendritic cells to activate an immune response specific to the patient`s disease.   Argos` most advanced product candidates include AGS-003 for the treatment of metastatic renal cell carcinoma, or mRCC, and AGS-004 for the treatment of HIV. Argos Therapeutics is headquartered in Research Triangle Park, NC. The Company has clinical stage programs in Phase 3 (metastatic renal cell carcinoma), Phase 2b (HIV) and Phase 1a (systemic lupus erythematosus1) development.

PRC

PRC is a global leader in AAC Solutions including for individuals with speech disorders. *This group does not provide official technical support.

Zeno Health

Mumbais #1 Generic Medicine Pharmacy 100+ Stores | 200 Crore+ Savings Delivered | Trusted by over 15 Lakhs+ Customer